GR852791B - - Google Patents

Info

Publication number
GR852791B
GR852791B GR852791A GR850102791A GR852791B GR 852791 B GR852791 B GR 852791B GR 852791 A GR852791 A GR 852791A GR 850102791 A GR850102791 A GR 850102791A GR 852791 B GR852791 B GR 852791B
Authority
GR
Greece
Prior art keywords
formulation
nose
mpa
eye
viscosity
Prior art date
Application number
GR852791A
Other languages
English (en)
Inventor
Emmett Clemente
Henry Pfeifer
Vincent Hon-Kin Lee
Joseph Robinson
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24706028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR852791(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of GR852791B publication Critical patent/GR852791B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
GR852791A 1984-11-23 1985-11-20 GR852791B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67428284A 1984-11-23 1984-11-23

Publications (1)

Publication Number Publication Date
GR852791B true GR852791B (el) 1986-03-21

Family

ID=24706028

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852791A GR852791B (el) 1984-11-23 1985-11-20

Country Status (18)

Country Link
EP (1) EP0183457B1 (el)
JP (1) JPH0639379B2 (el)
AT (1) ATE71524T1 (el)
AU (2) AU4999785A (el)
BE (1) BE903701A (el)
CA (1) CA1267848A (el)
CH (1) CH666816A5 (el)
DE (1) DE3585211D1 (el)
DK (1) DK541285A (el)
FR (1) FR2573652B1 (el)
GB (1) GB2167300B (el)
GR (1) GR852791B (el)
IE (1) IE59195B1 (el)
IL (1) IL77086A0 (el)
LU (1) LU86172A1 (el)
NZ (1) NZ214295A (el)
PT (1) PT81538A (el)
ZA (1) ZA858914B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
EP0444778A1 (en) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Use of alkyl saccharides to enhance the penetration of drugs
DE19539532C2 (de) * 1995-10-24 1999-02-25 Mann Gerhard Chem Pharm Fab Ophthalmisches Cromoglicat-Gelpräparat
WO2000042986A2 (de) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Künstliche tränenflüssigkeit in gelform
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
WO2005003111A1 (ja) * 2003-07-04 2005-01-13 Astellas Pharma Inc. ウィルス性結膜炎の予防または治療剤
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
ES2457442T3 (es) * 2009-05-08 2014-04-25 Pari Pharma Gmbh Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
JP2013231185A (ja) * 2013-06-12 2013-11-14 Pfizer Products Inc ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
US20160367520A1 (en) 2014-02-10 2016-12-22 Patara Pharma, LLC Mast cell stabilizers for lung disease treatment
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
CN109803724A (zh) 2016-10-07 2019-05-24 瑞思皮万特科学有限责任公司 用于治疗肺纤维化的色甘酸组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
US4268519A (en) * 1979-06-05 1981-05-19 Fisons Limited Method of treating otitis media
JPS5756448A (en) * 1980-09-22 1982-04-05 Mitsui Toatsu Chem Inc Preparation of aromatic isocyanate

Also Published As

Publication number Publication date
IL77086A0 (en) 1986-04-29
AU4431189A (en) 1990-02-22
IE852942L (en) 1986-05-23
GB2167300B (en) 1988-11-23
JPS61143318A (ja) 1986-07-01
BE903701A (fr) 1986-05-22
CH666816A5 (fr) 1988-08-31
GB2167300A (en) 1986-05-29
NZ214295A (en) 1988-07-28
EP0183457A3 (en) 1987-04-15
JPH0639379B2 (ja) 1994-05-25
AU4999785A (en) 1986-05-29
DE3585211D1 (de) 1992-02-27
DK541285D0 (da) 1985-11-22
CA1267848A (en) 1990-04-17
IE59195B1 (en) 1994-01-26
GB8528190D0 (en) 1985-12-18
FR2573652A1 (fr) 1986-05-30
LU86172A1 (fr) 1986-03-24
PT81538A (en) 1985-12-01
EP0183457A2 (en) 1986-06-04
FR2573652B1 (fr) 1988-09-02
ZA858914B (en) 1987-07-29
EP0183457B1 (en) 1992-01-15
ATE71524T1 (de) 1992-02-15
DK541285A (da) 1986-05-24

Similar Documents

Publication Publication Date Title
GR852791B (el)
DK486282A (da) Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider
AU549846B2 (en) Extraocular methof of treating the eye with liquid perfluorocarbons
SE8403090L (sv) Gel for anvendning som glaskroppssubstitut
GR3000536T3 (en) Penetration enhancement systems and the preparation thereof
DE3788004D1 (de) Verwendung von Tetrahydrocortisol in der Therapie von Glaukom.
DE3868892D1 (de) Verwendung von bisguanide enthaltenden zusammensetzungen gegen eier des madenwurms.
AU5629690A (en) Carboplatin composition
SE8801710L (sv) New ophtalmological composition of matter
DE3570076D1 (en) 2-sulfamoylbenzoûb¨furan derivatives and ophtalmic composition for the treatment of elevated intraocular pressure
EP0348527A4 (en) Antiallergic eye drop
AU1927183A (en) Method of thickening aqueous latex compositions
AU5992786A (en) Increasing aqueous humor outflow
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
KR860006065A (ko) 본체자면크기(body face size)치환에 따른 문자수식제어방식
SE8404130D0 (sv) New injectable compositions
IT1215319B (it) Formulazione acquosa di sodio cromo glicato con viscosita' compresa fra 2 e 300 mpa.s e metodo per prepararla
ES540308A0 (es) Un procedimiento de producir un agente promotor de la erec- cion y de la fertilidad
BR8300295A (pt) Emulsificador;processo de preparacao de uma emulsao contendo o emulsificador
UA24058A (uk) Спосіб стимулюваhhя репродуктивhих властивостей птахів